enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sulfinpyrazone - Wikipedia

   en.wikipedia.org/wiki/Sulfinpyrazone

   Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane. Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney.

3. Lesinurad - Wikipedia

   en.wikipedia.org/wiki/Lesinurad

   Lesinurad is used in combination with a xanthine oxidase inhibitor, such as allopurinol or febuxostat, for treating hyperuricemia (high levels of uric acid in the blood serum) associated with gout. It is approved only for patients who have not achieved target uric acid levels with a xanthine oxidase inhibitor alone.

4. Uricosuric - Wikipedia

   en.wikipedia.org/wiki/Uricosuric

   Uricosurics are often used in the treatment of gout, a disease in which uric acid crystals form deposits in the joints. By decreasing plasma uric acid levels, help dissolve these crystals, while limiting the formation of new ones. However, the increased uric acid levels in urine can contribute to kidney stones.

5. Your Gout Guide: From Symptoms to Treatment - AOL

   www.aol.com/gout-guide-symptoms-treatment...

   Lighter Side. Politics. Science & Tech. Sports. Weather. 24/7 Help. For premium support please call: ... Gout isn’t curable, but effective gout treatments are available. Because of this, it’s ...

6. Managing Out-of-Control Chronic Gout: Going Beyond Oral ...

   www.aol.com/lifestyle/managing-control-chronic...

   The post Managing Out-of-Control Chronic Gout: Going Beyond Oral Treatments appeared first on Reader's Digest. Do you sometimes have severe, unexplained pain in your joints, particularly in your ...

7. Pegloticase - Wikipedia

   en.wikipedia.org/wiki/Pegloticase

   Pegloticase (trade name Krystexxa) is a medication for the treatment of severe, treatment-refractory, chronic gout. It is a third line treatment in those in whom other treatments are not effective or are not tolerated. [2] The drug is administered by infusion intravenously. Since October 2023, Amgen Inc. has been the marketer of pegloticase in ...